GlaxoSmithKline (GSK)
NYSE:GSK

GlaxoSmithKline (GSK) Technical Analysis

4,618 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
6Neutral
14Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
GlaxoSmithKline’s (GSK) Moving Averages Convergence Divergence (MACD) indicator is -0.46, suggesting GlaxoSmithKline is a Sell.
GlaxoSmithKline’s (GSK) 20-Day exponential moving average is 39.37, while GlaxoSmithKline’s (GSK) share price is $39.3, making it a Sell.
GlaxoSmithKline’s (GSK) 50-Day exponential moving average is 40.34, while GlaxoSmithKline’s (GSK) share price is $39.3, making it a Sell.

GlaxoSmithKline (GSK) Pivot Points

Jul 24, 2024, 09:15 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
38.99
39.14
39.27
39.42
39.55
39.70
39.83
Fibonacci
39.14
39.25
39.32
39.42
39.53
39.60
39.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlaxoSmithKline (GSK) Moving Averages

Jul 24, 2024, 09:15 PM
Period
Simple
Exponential
MA5
39.36Sell
39.15Sell
MA10
39.10Sell
39.14Sell
MA20
38.92Sell
39.37Sell
MA50
41.33Sell
40.34Sell
MA100
41.50Sell
40.53Sell
MA200
39.24Sell
38.92Sell
GlaxoSmithKline’s (GSK) 10-Day exponential moving average is 39.14, while GlaxoSmithKline’s (GSK) share price is $39.3, making it a Sell.
GlaxoSmithKline’s (GSK) 100-Day exponential moving average is 40.53, while GlaxoSmithKline’s (GSK) share price is $39.3, making it a Sell.
GlaxoSmithKline’s (GSK) stock price is $39.3 and GlaxoSmithKline’s (GSK) 50-day simple moving average is 41.33, creating a Sell signal.
GlaxoSmithKline’s (GSK) stock price is $39.3 and GlaxoSmithKline’s (GSK) 100-day simple moving average is 41.50, creating a Sell signal.
GlaxoSmithKline’s (GSK) stock price is $39.3 and GlaxoSmithKline’s (GSK) 200-day simple moving average is 39.24, creating a Sell signal.

GlaxoSmithKline (GSK) Technical Indicators

Jul 24, 2024, 09:15 PM
Name
Value
Implied Action
RSI (14)
40.79
Neutral
STOCH (9,6)
49.89
Neutral
STOCHRSI (14)
63.59
Neutral
MACD (12,26)
-0.46
Sell
ADX (14)
23.08
Neutral
Williams %R
-55.84
Buy
CCI (14)
2.56
Neutral
ATR (14)
0.59
-
Ultimate Oscillator
50.15
Neutral
ROC
1.65
Buy
GlaxoSmithKline’s (GSK) Relative Strength Index (RSI) is 40.79, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Trend Strength Indicator (ADX) is 23.08, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Commodity Channel Index (CCI) is 2.56, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Price Rate of Change (ROC) is 1.65, creating a Buy signal.

FAQ

Is GSK a Buy, Hold, or Sell?
Based on GSK’s technical indicators, GSK is a Strong Sell.
    What is GSK’s RSI (14)?
    GSK’s RSI (14) is 40.79, which suggests GSK is a Neutral.
      What is GSK’s MACD?
      GSK’s MACD is -0.46, which suggests GSK is a Sell.
        What is GSK’s 5-day moving average?
        GSK’s 5-day moving average is 39.36, which suggests GSK is a Sell.
          What is GSK’s 20-day moving average?
          GSK 20-day moving average is 38.92, which suggests GSK is a Sell.
            What is GSK’s 50-day moving average?
            GSK’s 50-day moving average is 41.33, which suggests GSK is a Sell.
              What is GSK’s 200-day moving average?
              GSK’s 200-day moving average is 39.24, which suggests GSK is a Sell.
                What is GSK’s Williams % R (14)?
                GSK’s Williams % R (14) is -55.84, which suggests GSK is a Buy.
                  What is GSK’s CCI (14)?
                  GSK’s CCI (14) is 2.56, which suggests GSK is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis